Self-assembling prodrugs composed of antimicrobial peptides spontaneously form nanostructures that improve stability, targeting, and controlled release — revolutionizing AMP delivery.
Drug IS the delivery systemAMP prodrugs self-assemble into their own nanoparticle carriers — eliminating carrier materials while improving stability and targeting
What the researchers found
Self-assembling AMP prodrugs: spontaneous nanostructure formation providing stability, targeting, and controlled release without carrier materials — carrier-free AMP delivery revolution.
Why it matters
AMP delivery is the biggest barrier to clinical use. Self-assembling prodrugs eliminate the carrier — the AMP IS the delivery system.
How the study worked
Review of self-assembling AMP prodrug design, nanostructure formation, and therapeutic applications.
What this study cannot tell us
Emerging field. Many designs still preclinical.
How to read the evidence
Review of emerging self-assembling AMP prodrug field.
When this study was published
Published in 2025.
The bigger picture
Self-assembling prodrugs represent the ultimate simplification of drug delivery — the drug molecule itself becomes the delivery vehicle.
Questions still open
- Which AMP sequences best self-assemble into therapeutic nanostructures?
- Can assembly be triggered by infection-site stimuli?
- Would self-assembling AMPs maintain activity after disassembly?
Common questions
What is a self-assembling AMP prodrug?
Why is this revolutionary?
Read the original research
Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actor.
Drug delivery and translational research
Citation
Ladaycia, Abdallah; Lemaire, Laurent; Pailhoriès, Hélène; Lautram, Nolwenn; Franconi, Florence; Pigeon, Pascal; Jaouen, Gérard; Passirani, Catherine; Lepeltier, Elise. (2026). Self-assemblies from prodrugs composed of antimicrobial peptides: a revolution in local lung cancer treatment, with microbiota as a main actor.. Drug delivery and translational research. https://doi.org/10.1007/s13346-025-02037-x